Effect of Pomegranate Juice Consumption on the Health of Mothers and Infants During Breastfeeding
PomInfant
Observational Pilot Study on Pomegranate Metabolism in Breastfeeding Women and Their Infants
1 other identifier
interventional
11
1 country
1
Brief Summary
Breast milk is universally recognized as the best food for newborns. Studies have scientifically shown that breastfeeding provides optimal nutrients for infants, strengthens their immune system, and improves mother-and-child bonding. Demonstrating health benefits of pomegranate consumption on infant health could lead to greater incentive for women to breast feed. The purpose of this research study is to determine whether pomegranate metabolites (products produced by breakdown) is secreted into breastmilk and whether they have an effect on breast-fed infants who are born vaginally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2019
CompletedFirst Submitted
Initial submission to the registry
April 7, 2020
CompletedFirst Posted
Study publicly available on registry
April 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2020
CompletedAugust 4, 2020
August 1, 2020
1.2 years
April 7, 2020
August 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pomegranate Juice Metabolism
To examine the metabolism of pomegranate by analyzing blood, urine, breast milk and stool samples for ellagic acid and urolithin levels before and after administration of pomegranate extract for 2 weeks during breastfeeding in healthy mothers.
2 weeks
Microbiome
To determine whether pomegranate metabolites are bioavailable to breastfed infants by analyzing ellagic acid in urine and stool from infants of mothers consuming PJ.
2 weeks
Microbiome
To determine whether pomegranate metabolites are bioavailable to breastfed infants by analyzing urolithin in urine and stool from infants of mothers consuming PJ.
2 weeks
Study Arms (1)
Pom Juice
EXPERIMENTALThe study participants will all be asked to drink pomegranate juice for 2 weeks, and 4 weeks of continued usual diet and avoid pomegranate juice (other than what is given to you), berries (strawberries, blackberries, raspberries (red, black, yellow), cranberries), walnuts, pecans, hazelnuts, pecans, chestnuts, red and white guava, pomegranates, flaxseeds, dark chocolate and cocoa, coffee, tea, rose hip, olives, artichoke, dried herbs and beefsteak tongue mushrooms).
Interventions
Eligibility Criteria
You may qualify if:
- Postpartum 6 months with full term baby born vaginally and exclusively breast feeding
- In good health
- Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.
You may not qualify if:
- No antibiotics or laxatives use during the 2 months before the study.
- Any subject consuming pre- or probiotics or anti-inflammatory medication
- Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
- Any subject who is unable or unwilling to comply with the study protocol.
- Allergic to pomegranate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA Center for Human Nutrition, 1000 Veteran Ave.
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhaoping Li, MD
UCLA Professor of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 7, 2020
First Posted
April 10, 2020
Study Start
May 8, 2019
Primary Completion
July 31, 2020
Study Completion
July 31, 2020
Last Updated
August 4, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share